Neogen (NEOG)
(Real Time Quote from BATS)
$16.44 USD
+0.11 (0.67%)
Updated Jul 22, 2024 11:52 AM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
Income Statements
Fiscal Year end for Neogen Corporation falls in the month of May .
All items in Millions except EPS data.
5/31/24 | 5/31/23 | 5/31/22 | 5/31/21 | 5/31/20 | |
---|---|---|---|---|---|
Sales | NA | 822 | 527 | 468 | 418 |
Cost Of Goods | NA | 416 | 284 | 253 | 222 |
Gross Profit | NA | 406 | 243 | 215 | 196 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 368 | 184 | 141 | 129 |
Income After Depreciation & Amortization | 0 | 38 | 59 | 74 | 68 |
Non-Operating Income | NA | -4 | 2 | 1 | 5 |
Interest Expense | NA | 56 | 0 | 0 | 0 |
Pretax Income | NA | -22 | 60 | 75 | 72 |
Income Taxes | NA | 1 | 12 | 14 | 13 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | -23 | 48 | 61 | 59 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | -23 | 48 | 61 | 59 |
Depreciation Footnote | 5/31/24 | 5/31/23 | 5/31/22 | 5/31/21 | 5/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 129 | 82 | 95 | 86 |
Depreciation & Amortization (Cash Flow) | NA | 91 | 24 | 21 | 18 |
Income After Depreciation & Amortization | 0 | 38 | 59 | 74 | 68 |
Earnings Per Share Data | 5/31/24 | 5/31/23 | 5/31/22 | 5/31/21 | 5/31/20 |
---|---|---|---|---|---|
Average Shares | NA | 188.88 | 108.02 | 107.12 | 105.72 |
Diluted EPS Before Non-Recurring Items | NA | 0.56 | 0.63 | 0.57 | 0.57 |
Diluted Net EPS (GAAP) | NA | -0.12 | 0.45 | 0.57 | 0.57 |
Fiscal Year end for Neogen Corporation falls in the month of May .
All items in Millions except EPS data.
5/31/24 | 2/29/24 | 11/30/23 | 8/31/23 | 5/31/23 | |
---|---|---|---|---|---|
Sales | NA | 228.81 | 229.63 | 228.99 | 241.81 |
Cost Of Goods | NA | 111.93 | 112.86 | 112.23 | 118.63 |
Gross Profit | NA | 116.88 | 116.77 | 116.76 | 123.18 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 104.86 | 102.31 | 97.62 | 99.75 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 12.02 | 14.46 | 19.14 | 23.43 |
Non-Operating Income | NA | 0.44 | -0.18 | 0.98 | 2.18 |
Interest Expense | NA | 18.29 | 18.03 | 18.46 | 17.96 |
Pretax Income | NA | -5.82 | -3.75 | 1.66 | 7.65 |
Income Taxes | NA | -3.80 | -0.26 | 0.16 | 2.08 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -2.02 | -3.49 | 1.50 | 5.57 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -2.02 | -3.49 | 1.50 | 5.57 |
Earnings Per Share Data | 5/31/24 | 2/29/24 | 11/30/23 | 8/31/23 | 5/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 216.60 | 216.41 | 216.85 | 216.44 |
Diluted EPS Before Non-Recurring Items | NA | 0.12 | 0.11 | 0.11 | 0.14 |
Diluted Net EPS (GAAP) | NA | -0.01 | -0.02 | 0.01 | -0.02 |